These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9141190)

  • 1. Bacterial phospholipases and their role in virulence.
    Songer JG
    Trends Microbiol; 1997 Apr; 5(4):156-61. PubMed ID: 9141190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial phospholipases.
    Titball RW
    Trends Microbiol; 1997 Jul; 5(7):265. PubMed ID: 9234505
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial phospholipases C with dual activity: phosphatidylcholinesterase and sphingomyelinase.
    Monturiol-Gross L; Villalta-Romero F; Flores-Díaz M; Alape-Girón A
    FEBS Open Bio; 2021 Dec; 11(12):3262-3275. PubMed ID: 34709730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial phospholipases and intracellular growth: the two distinct phospholipases C of Listeria monocytogenes.
    Goldfine H; Bannam T; Johnston NC; Zückert WR
    Symp Ser Soc Appl Microbiol; 1998; 27():7S-14S. PubMed ID: 9750357
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.
    Sayeed S; Uzal FA; Fisher DJ; Saputo J; Vidal JE; Chen Y; Gupta P; Rood JI; McClane BA
    Mol Microbiol; 2008 Jan; 67(1):15-30. PubMed ID: 18078439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clostridium perfringens and gas gangrene].
    Lindsay D
    Zentralbl Chir; 1986; 111(6):314-23. PubMed ID: 2872759
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of two phospholipases in the pathogenicity of Listeria monocytogenes.
    Smith GA; Portnoy DA
    Infect Agents Dis; 1993 Aug; 2(4):183-5. PubMed ID: 8173791
    [No Abstract]   [Full Text] [Related]  

  • 10. Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-kappa B activation, and E-selectin expression in human endothelial cells.
    Schwarzer N; Nöst R; Seybold J; Parida SK; Fuhrmann O; Krüll M; Schmidt R; Newton R; Hippenstiel S; Domann E; Chakraborty T; Suttorp N
    J Immunol; 1998 Sep; 161(6):3010-8. PubMed ID: 9743365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence factors of Clostridium perfringens.
    Smith LD
    Rev Infect Dis; 1979; 1(2):254-62. PubMed ID: 232935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the key toxin in gas gangrene.
    Naylor CE; Eaton JT; Howells A; Justin N; Moss DS; Titball RW; Basak AK
    Nat Struct Biol; 1998 Aug; 5(8):738-46. PubMed ID: 9699639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of multiple signal peptidases in the virulence of Listeria monocytogenes.
    Bonnemain C; Raynaud C; Réglier-Poupet H; Dubail I; Frehel C; Lety MA; Berche P; Charbit A
    Mol Microbiol; 2004 Mar; 51(5):1251-66. PubMed ID: 14982622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular studies on the virulence of Listeria monocytogenes.
    Kuhn M; Goebel W
    Genet Eng (N Y); 1995; 17():31-51. PubMed ID: 7779515
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-toxin of Clostridium perfringens is not an essential virulence factor in necrotic enteritis in chickens.
    Keyburn AL; Sheedy SA; Ford ME; Williamson MM; Awad MM; Rood JI; Moore RJ
    Infect Immun; 2006 Nov; 74(11):6496-500. PubMed ID: 16923791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the virulence factor expression level in Listeria monocytogenes under various environmental conditions].
    Ermolaeva SA; Belyĭ IuF; Tartakovskiĭ IS
    Mol Gen Mikrobiol Virusol; 2000; (1):17-9. PubMed ID: 10702985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase C and sphingomyelinase activities of the Clostridium perfringens alpha-toxin.
    Urbina P; Flores-Díaz M; Alape-Girón A; Alonso A; Goni FM
    Chem Phys Lipids; 2009 May; 159(1):51-7. PubMed ID: 19428363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring Clostridium perfringens nontoxic alpha-toxin variant as a potential vaccine candidate against alpha-toxin-associated diseases.
    Schoepe H; Pache C; Neubauer A; Potschka H; Schlapp T; Wieler LH; Baljer G
    Infect Immun; 2001 Nov; 69(11):7194-6. PubMed ID: 11598102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Foodborne Listeria monocytogenes: are all the isolates equally virulent?].
    López V; Suárez M; Chico-Calero I; Navas J; Martínez-Suárez JV
    Rev Argent Microbiol; 2006; 38(4):224-34. PubMed ID: 17370579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells.
    Steinthorsdottir V; Halldórsson H; Andrésson OS
    Microb Pathog; 2000 Jan; 28(1):45-50. PubMed ID: 10623563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.